Literature DB >> 15761054

The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodies.

Hua-Poo Su1, Scott C Garman, Timothy J Allison, Christiana Fogg, Bernard Moss, David N Garboczi.   

Abstract

Although eradicated from nature more than two decades ago, the threat of smallpox has reemerged because of concerns over its use as a biological weapon. We present the structure of the poxvirus L1 protein, a molecule that is conserved throughout the poxvirus family and is nearly identical in vaccinia virus and in variola virus, which causes smallpox. L1 is a myristoylated envelope protein that is a potent target for neutralizing antibodies and an important component of current experimental vaccines. The L1 structure reveals a hydrophobic cavity located adjacent to its N terminus. The cavity would be capable of shielding the myristate moiety, which is essential for virion assembly. The structure of L1 is a step in the elucidation of molecular mechanisms common to all poxviruses that may stimulate the design of safer vaccines and new antipoxvirus drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761054      PMCID: PMC555483          DOI: 10.1073/pnas.0501103102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Software for handling macromolecular envelopes.

Authors:  G J Kleywegt; T A Jones
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

2.  Structure of the reovirus membrane-penetration protein, Mu1, in a complex with is protector protein, Sigma3.

Authors:  Susanne Liemann; Kartik Chandran; Timothy S Baker; Max L Nibert; Stephen C Harrison
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

3.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

Review 5.  Poliovirus cell entry: common structural themes in viral cell entry pathways.

Authors:  James M Hogle
Journal:  Annu Rev Microbiol       Date:  2002-01-30       Impact factor: 15.500

6.  Complete pathway for protein disulfide bond formation encoded by poxviruses.

Authors:  Tatiana G Senkevich; Christine L White; Eugene V Koonin; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 7.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Authors:  D A Henderson; T V Inglesby; J G Bartlett; M S Ascher; E Eitzen; P B Jahrling; J Hauer; M Layton; J McDade; M T Osterholm; T O'Toole; G Parker; T Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  1999-06-09       Impact factor: 56.272

8.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

9.  Maximum-likelihood density modification.

Authors:  T C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-08

10.  Automated main-chain model building by template matching and iterative fragment extension.

Authors:  Thomas C Terwilliger
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-12-19
View more
  31 in total

1.  Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein.

Authors:  Erica Brown; Tatiana G Senkevich; Bernard Moss
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein.

Authors:  Hua-Poo Su; Joseph W Golden; Apostolos G Gittis; Jay W Hooper; David N Garboczi
Journal:  Virology       Date:  2007-08-03       Impact factor: 3.616

3.  The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains.

Authors:  Hua-Poo Su; Kavita Singh; Apostolos G Gittis; David N Garboczi
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

Review 4.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

5.  Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5.

Authors:  Michael H Matho; Matt Maybeno; Mohammed Rafii-El-Idrissi Benhnia; Danielle Becker; Xiangzhi Meng; Yan Xiang; Shane Crotty; Bjoern Peters; Dirk M Zajonc
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry.

Authors:  Chwan Hong Foo; J Charles Whitbeck; Manuel Ponce-de-León; Wan Ting Saw; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2012-03-07       Impact factor: 5.103

Review 7.  Chemistry and Enzymology of Disulfide Cross-Linking in Proteins.

Authors:  Deborah Fass; Colin Thorpe
Journal:  Chem Rev       Date:  2017-07-12       Impact factor: 60.622

8.  Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.

Authors:  Yuhong Xiao; Yuhong Zeng; Edward Alexander; Shyam Mehta; Sangeeta B Joshi; George W Buchman; David B Volkin; C Russell Middaugh; Stuart N Isaacs
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

9.  Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.

Authors:  Thomas Kaever; Xiangzhi Meng; Michael H Matho; Andrew Schlossman; Sheng Li; Inbal Sela-Culang; Yanay Ofran; Mark Buller; Ryan W Crump; Scott Parker; April Frazier; Shane Crotty; Dirk M Zajonc; Bjoern Peters; Yan Xiang
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

10.  Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.

Authors:  Mohammed Rafii-El-Idrissi Benhnia; Megan M McCausland; Hua-Poo Su; Kavita Singh; Julia Hoffmann; D Huw Davies; Philip L Felgner; Steven Head; Alessandro Sette; David N Garboczi; Shane Crotty
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.